AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
27.67
-0.42 (-1.50%)
May 29, 2026, 4:00 PM EDT - Market closed
AtriCure Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -4.59 | -11.45 | -44.7 | -30.44 | -46.47 | 50.2 |
Depreciation & Amortization | 20.72 | 20.53 | 18.73 | 14.81 | 11.71 | 10.44 |
Stock-Based Compensation | 46.33 | 44.69 | 40.41 | 35.73 | 28.77 | 28.08 |
Other Adjustments | 5.55 | 7.85 | 16.12 | 2.62 | 2.72 | -97.65 |
Change in Receivables | -7.94 | -5.61 | -8.3 | -9.87 | -8.99 | -10.09 |
Changes in Inventories | -5.78 | -2.26 | -7.74 | -21.83 | -7.31 | -4.27 |
Changes in Accounts Payable | 5.33 | -0.96 | -1.53 | 6.18 | 2.68 | 4.71 |
Changes in Accrued Expenses | 6.05 | 7 | 1.2 | 11.56 | -2.97 | 8.27 |
Changes in Other Operating Activities | -3.81 | -2.46 | -1.99 | -4.28 | -2.3 | -3.47 |
Operating Cash Flow | 64.36 | 57.33 | 12.2 | 4.48 | -22.14 | -13.78 |
Operating Cash Flow Growth | 190.01% | 369.80% | 172.17% | - | - | - |
Capital Expenditures | -10.72 | -9.05 | -11.46 | -12 | -16.88 | -9.75 |
Sale of Property, Plant & Equipment | - | - | 0.03 | - | - | - |
Purchases of Investments | - | - | - | - | -24.64 | -173.11 |
Proceeds from Sale of Investments | - | - | 53.67 | 63.82 | 85.52 | 206.36 |
Payments for Business Acquisitions | -3.5 | -6 | -12 | -30 | - | - |
Other Investing Activities | - | 0.5 | - | - | - | - |
Investing Cash Flow | -16.72 | -14.55 | 30.23 | 21.82 | 44.01 | 23.5 |
Long-Term Debt Issued | - | - | 61.21 | - | - | 5 |
Long-Term Debt Repaid | -2.11 | -1.2 | -62.88 | -0.99 | -0.9 | -5.82 |
Net Long-Term Debt Issued (Repaid) | -2.11 | -1.2 | -1.67 | -0.99 | -0.9 | -0.82 |
Issuance of Common Stock | 1.39 | 7.29 | 6.09 | 7.58 | 6.04 | 12.36 |
Repurchase of Common Stock | -12.43 | -11.16 | -6.95 | -6.56 | -12.2 | -18.01 |
Net Common Stock Issued (Repurchased) | -11.04 | -3.87 | -0.87 | 1.02 | -6.16 | -5.66 |
Other Financing Activities | -0.78 | 6.25 | -1.07 | -0.06 | - | -1.17 |
Financing Cash Flow | -1.75 | 1.18 | -3.6 | -0.03 | -7.06 | -7.64 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.39 | 0.75 | -0.42 | -0.06 | -0.36 | -0.37 |
Net Cash Flow | 46.28 | 44.71 | 38.41 | 26.21 | 14.45 | 1.71 |
Free Cash Flow | 53.64 | 48.28 | 0.75 | -7.51 | -39.02 | -23.53 |
Free Cash Flow Growth | 11.10% | 6381.07% | - | - | - | - |
FCF Margin | 9.72% | 9.03% | 0.16% | -1.88% | -11.81% | -8.58% |
Free Cash Flow Per Share | 1.11 | 1.01 | 0.02 | -0.16 | -0.85 | -0.51 |
Levered Free Cash Flow | 5.1 | 0.16 | -49.15 | -36.98 | -62.43 | 55.31 |
Unlevered Free Cash Flow | 7.62 | 2.16 | -43.73 | -32.76 | -57.98 | 60.93 |